help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-0228
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tong, P. C. Y.
Right arrow Articles by Chan, J. C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tong, P. C. Y.
Right arrow Articles by Chan, J. C. N.
Related Collections
Right arrow Cardiovascular Endocrinology
Right arrow Diabetes and Insulin
Right arrow Male Endocrinology
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 12 6418-6423
Copyright © 2005 by The Endocrine Society

Association of Testosterone, Insulin-Like Growth Factor-I, and C-Reactive Protein with Metabolic Syndrome in Chinese Middle-Aged Men with a Family History of Type 2 Diabetes

Peter C. Y. Tong, Chung-Shun Ho, Vincent T. F. Yeung, Maggie C. Y. Ng, Wing-Yee So, Risa Ozaki, Gary T. C. Ko, Ronald C. W. Ma, Emily Poon, Norman N. Chan, Christopher W. K. Lam and Juliana C. N. Chan

Departments of Medicine and Therapeutics (P.C.Y.T., M.C.Y.N., W.-Y.S., R.O., R.C.W.M., E.P., J.C.N.C.) and Chemical Pathology (C.-S.H., C.W.K.L.), Qualigenics Diabetes Centre (N.N.C.), Postgraduate Education Centre, School of Public Health, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong; Our Lady of Maryknoll Hospital (V.T.F.Y.), Wong Tai Sin, Hong Kong; Alice Ho Nethersole Hospital (G.T.C.K.), Tai Po, Hong Kong; and Howard Hughes Research Institute (M.C.Y.N.), University of Chicago, Chicago, Illinois 60637

Address all correspondence and requests for reprints to: Dr. Peter Tong, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong. E-mail: ptong{at}cuhk.edu.hk.

Context: Age-related declines in testosterone and IGF-I are associated with deposition of visceral fat, a component of the metabolic syndrome (MES).

Objective: Testosterone and IGF-I may interact with familial disposition to diabetes mellitus to increase the association with MES.

Design: We conducted a cross-sectional cohort study.

Setting: The study was conducted in a university teaching hospital.

Subjects: Study subjects included 179 middle-aged men with a family history of diabetes (FH) (aged 39.1 ± 8.1 yr) and 128 men without FH (aged 43.8 ± 8.5 yr).

Main Outcome Measures: Clinical characteristics, frequency of MES using the World Health Organization criteria with Asian definitions of obesity (body mass index ≥ 25 kg/m2), and serum levels of total testosterone, IGF-I, and high-sensitive C-reactive protein (hs-CRP) were measured.

Results: Men with FH had higher frequency of MES than those without FH [39.1 vs. 23.4% (P = 0.004)]. On multivariate analysis, smoking (former and current smokers), low total testosterone, and IGF-I but elevated hs-CRP levels explained 35% of the MES variance in men with FH. The frequency of MES increased with declining tertiles of total testosterone and IGF-I but increasing tertiles of hs-CRP. After adjustment for age and smoking history, subjects with all three risk factors had a 13-fold increase in risk association with MES compared with those without hormonal and inflammatory risk factors. These risk associations were not found in men without FH in whom only smoking (ex and current) and low total testosterone level were independent predictors for MES, which explained 14% of the variance.

Conclusions: Clustering of FH, hormonal abnormalities, and high hs-CRP is associated with MES in Chinese middle-aged men.




This article has been cited by other articles:


Home page
JAMAHome page
J. C. N. Chan, V. Malik, W. Jia, T. Kadowaki, C. S. Yajnik, K.-H. Yoon, and F. B. Hu
Diabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
JAMA, May 27, 2009; 301(20): 2129 - 2140.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Kucic, I. B. Copland, J. Cuerquis, D. L. Coutu, L. E. Chalifour, R. F. Gagnon, and J. Galipeau
Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F488 - F496.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society